The impact of sarcopenia on the efficacy and safety of immune checkpoint inhibitors in patients with solid tumours.

  1. Haik, L, Gonthier, A, Quivy, A, Gross-Goupil, M, Veillon, R, Frison, E et al.. The impact of sarcopenia on the efficacy and safety of immune checkpoint inhibitors in patients with solid tumours. Acta Oncol. 2021;60 (12):1597-1603. doi: 10.1080/0284186X.2021.1978540. PubMed PMID:34549686 .
Search PubMed

People Involved

All right reserved © immunoconcept.cnrs.fr 2022 by Nivo-Web

Scroll to Top